ARCH Venture Partners IX, LLC - Aug 12, 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
10%+ Owner
Signature
By: ARCH Venture Partners IX, LLC, By: /s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
Stock symbol
VIR
Transactions as of
Aug 12, 2022
Transactions value $
$0
Form type
4
Date filed
8/16/2022, 09:04 PM
Previous filing
Jun 10, 2022
Next filing
Aug 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -218K -2.79% $0.00 7.59M Aug 12, 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282K -2.79% $0.00 9.83M Aug 12, 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +13.1K +9.19% $0.00 155K Aug 12, 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1.48K +9.33% $0.00 17.3K Aug 12, 2022 Direct F1, F4, F6
transaction VIR Common Stock Other $0 +2.95K +9.33% $0.00 34.6K Aug 12, 2022 See footnote F1, F4, F7
transaction VIR Common Stock Other $0 -218K -2.87% $0.00 7.37M Aug 15, 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282K -2.87% $0.00 9.55M Aug 15, 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +13.1K +8.42% $0.00 168K Aug 15, 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1.48K +8.53% $0.00 18.8K Aug 15, 2022 Direct F1, F4, F6
transaction VIR Common Stock Other $0 +2.95K +8.54% $0.00 37.5K Aug 15, 2022 See footnote F1, F4, F7
transaction VIR Common Stock Other $0 -218K -2.96% $0.00 7.15M Aug 16, 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282K -2.96% $0.00 9.27M Aug 16, 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +13.1K +7.77% $0.00 181K Aug 16, 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1.48K +7.86% $0.00 20.2K Aug 16, 2022 Direct F1, F4, F6
transaction VIR Common Stock Other $0 +2.95K +7.86% $0.00 40.5K Aug 16, 2022 See footnote F1, F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of Common Stock held by a limited partnership to its partners for no consideration.
F2 These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
F3 These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
F4 Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
F5 Shares held directly by Crandell.
F6 Shares held directly by Bybee.
F7 Shares held by a trust for the benefit of family members of Bybee.